Clinical trials: Paracetamol Toxicity
Paracetamol Toxicity
Evaluation of Differences Between the Standered NAC Regimen Protocol and the SNAP Regimen Protocol in the Treatment of Paracetamol Toxicity for Cases Presented Early and Late to Assiut University Hospitals in Terms of Safety and Efficiecy.
Evaluation of differences between the 21 h NAC regimen protocol and the 12 h NAC regimen protocol in the treatment of paracetamol toxicity (over dose) for cases presented early and late to Assiut University Hospitals in terms of…
- Trial name
- NCT07454590
- Testing
- Evidence-based medical care for paracetamol toxicity
- Where
- Egypt
- Volunteers
- 102 people
- Sponsor
- Assiut University
Paracetamol Toxicity, Hepatotoxicity
APAP Hepatotoxicity After Therapeutic Doses
Paracetamol (acetaminophen, APAP) is the most commonly used antipyretic and painkiller worldwide, but also the leading cause of acute liver failure (ALF) in developed countries after supra-therapeutic doses (half overdoses being…
- Conditions
- Paracetamol Toxicity, Hepatotoxicity, Malnutrition
- Trial name
- NCT03602274
- Testing
- Hepatic function monitoring, Nutritional status assesment, Biomarker research sampling
- Where
- Switzerland
- Volunteers
- 96 people
- Sponsor
- University Hospital, Geneva